International journal of molecular sciences

Modified mRNA in Immune Cells Helps Produce Effective Cancer-Fighting T Cells

Updated

Abstract

m1Ψ modification increased protein production in dendritic cells by up to 20-fold compared with unmodified mRNA.

  • Modified mRNA with 1-methyl-pseudouridine may enhance antigen expression in human dendritic cells.
  • Dendritic cells using m1Ψ-modified mRNA effectively primed CD8+ T cells specific to survivin and MART-1.
  • These antigen-specific T cell lines demonstrated strong effector functions, including production of IFN-γ and cytotoxic activity.
  • The efficiency of m1Ψ modification is associated with the poly(A) tail of the mRNA.
  • Findings support the potential for m1Ψ modification in advancing mRNA-based cancer therapies.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free